Health & Veritas

Howie and Harlan are joined by Dr. Cecelia Calhoun '21, a Yale sickle cell disease specialist and a recipient of Yale SOM's Pozen-Commonwealth Fund Fellowship in Health Equity Leadership. They discuss Calhoun's journey from growing up in Detroit to a clinical and research career focused on the health of the Black community. Links Pozen-Commonwealth Fund Fellowship in Health Equity Leadership "Hear...

Howie and Harlan are joined by Dr. Gail D'Onofrio, Yale's Albert E. Kent Professor of Emergency Medicine. They discuss the medications available for opioid addiction and the policy changes needed to allow those treatments to save more lives.  Links "Sex-Specific Risk Factors Associated With First Acute Myocardial Infarction in Young Adults" "Medication for Opioid Use Disorder After Nonfatal Opioid...

Howie and Harlan talk with Yale's Melinda Irwin about her research investigating how lifestyle factors impact the prevention and treatment of cancer. Links "Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19" "Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers" "Physical Activity and Health: A Report of the Su...

To do better in the next pandemic, Sherry Glied, dean of New York University's Robert F. Wagner Graduate School of Public Service, argues we must ensure that policymakers get answers to their most pressing questions. She joins Howie and Harlan in a conversation about incentivizing relevant research and systematically synthesizing data into actionable information.

Howie and Harlan talk with NYU's Lauren Taylor about the "dirty hands problem" and other ethical dilemmas inherent in efforts to improve health.

Howie and Harlan are joined by Dr. Ezekiel Emanuel, a leading expert on health policy and medical ethics, for a conversation about how to bring greater efficiency and agility to the generation of healthcare knowledge.

Howie and Harlan discuss a new study showing that moderate drinking doesn't have health benefits after all. Then they're joined by Dr. Daniel Stein, CEO of Embold Health, which uses clinical data to identify the best-performing doctors and give feedback to those whose treatment isn't based on the latest evidence. 

Howie and Harlan are joined by Yale operations expert Edward Kaplan, who uses mathematical models to understand a variety of processes. They discuss Kaplan's ongoing research tracking COVID-19 infections through sewage, which bypasses the biases inherent in data from testing and even hospitalization.

Howie and Harlan are joined by Dr. Lakshmanan Krishnamurti, chief of pediatric hematology and oncology at the Yale School of Medicine and an expert on sickle cell disease. They discuss promising new treatments that can effectively cure the painful disease for some patients. 

Howie and Harlan are joined by Dr. Kristin Mattocks, a researcher at the University of Massachusetts and the Department of Veteran's Affairs. They discuss her research on the complexities of healthcare for the growing number of women veterans. 

Howie and Harlan talk with Dr. Mandy Cohen, former secretary of the North Carolina Department of Health and Human Services and the CEO of Aledade Care Solutions. They discuss how to create the incentives and infrastructure needed for better outcomes for all patients.  

Howie and Harlan talk with Dr. Ijeoma Opara of the Yale School of Public Health about the impact of persistent violence on mental health among urban youth and the power of community-based participatory research. 

Howie and Harlan are joined by Dr. Saad Omer, director of the Yale Institute for Global Health. They discuss mistakes made in the rollout of COVID-19 vaccines and how to avoid a crisis in childhood immunizations. 

Howie and Harlan are joined by Dr. Emily Wang, director of Yale's  SEICHE Center for Health and Justice , to discuss the health effects of mass incarceration on the imprisoned and their families and communities.

Howie and Harlan talk with Dr. Akiko Iwasaki about her research trying to understand the cause or causes of long COVID, which has over 200 reported symptoms.

Howie and Harlan discuss two recent studies (one of them co-authored by Harlan) illustrating the health impacts of racism. Then they're joined by Randi Epstein, a physician and journalist whose most recent book is Aroused: The History of Hormones and How They Control Just About Everything.

Howie and Harlan are joined by Yale epidemiologist Nathan Grubaugh. They discuss the utility of rapid antigen tests and Grubaugh's work tracking the evolution of COVID-19 variants.

Howie and Harlan talk about the patients who test positive for COVID-19 after being admitted to the hospital for something else, and other health issues in the news, including the explosion in healthcare spending last year, a controversial Alzheimer's drug, and the consequences of underinsurance in the United States.

Howie and Harlan discuss the state of the omicron surge and what we know and don't know about the variant. Then they're joined by Yale scientist Anne Wyllie, whose new research casts doubt on the ability of rapid antigen tests to detect asymptomatic omicron infections.

Howie and Harlan are joined by Dr. Albert Ko, a Yale epidemiologist who has advised Connecticut governor Ned Lamont. They discuss the state of the pandemic, rebuilding global public health infrastructure, and what omicron tells us about future variants.

Howie and Harlan are joined by Yale economist Fiona Scott Morton, an expert on competition in healthcare and other industries. They discuss the forces driving up healthcare costs in the U.S. and the steps that Scott Morton and her colleagues have proposed to bring them under control.

Howie and Harlan are joined by Liza Fisher to talk about her experience navigating the medical system and advocating for patients while enduring 18 months of debilitating COVID symptoms. Fisher is a participant and co-author (with Harlan) for a new study examining internal tremors and vibrations among long COVID patients. 

Howie and Harlan discuss what we know and don't know about the newly identified omicron variant. Then they're joined by Dr. Joseph Ross to discuss the strengths and weaknesses of the FDA's process for approving new drugs.

Howie and Harlan talk with Dr. Rohan Khera, a Yale cardiologist whose research interests include the use of advanced data science tools to improve diagnosis and treatment. They discuss how artificial intelligence and machine learning can supplement human expertise in summarizing current literature, interpreting electrocardiograms, and other areas.

Howie and Harlan are joined by Jason Abaluck, a health economist at the Yale School of Management. They discuss a massive study co-authored by Abaluck that showed that masks reduce COVID infections in a community setting.